Your browser doesn't support javascript.
loading
Structure of the endosomal Commander complex linked to Ritscher-Schinzel syndrome.
Healy, Michael D; McNally, Kerrie E; Butkovic, Rebeka; Chilton, Molly; Kato, Kohji; Sacharz, Joanna; McConville, Calum; Moody, Edmund R R; Shaw, Shrestha; Planelles-Herrero, Vicente J; Yadav, Sathish K N; Ross, Jennifer; Borucu, Ufuk; Palmer, Catherine S; Chen, Kai-En; Croll, Tristan I; Hall, Ryan J; Caruana, Nikeisha J; Ghai, Rajesh; Nguyen, Thi H D; Heesom, Kate J; Saitoh, Shinji; Berger, Imre; Schaffitzel, Christiane; Williams, Tom A; Stroud, David A; Derivery, Emmanuel; Collins, Brett M; Cullen, Peter J.
Afiliación
  • Healy MD; Centre for Cell Biology of Chronic Disease, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.
  • McNally KE; School of Biochemistry, Biomedical Sciences Building, University of Bristol, BS8 1TD Bristol, UK; MRC Laboratory of Molecular Biology, CB2 0QH Cambridge, UK. Electronic address: kmcnally@mrc-lmb.cam.ac.uk.
  • Butkovic R; School of Biochemistry, Biomedical Sciences Building, University of Bristol, BS8 1TD Bristol, UK.
  • Chilton M; School of Biochemistry, Biomedical Sciences Building, University of Bristol, BS8 1TD Bristol, UK.
  • Kato K; School of Biochemistry, Biomedical Sciences Building, University of Bristol, BS8 1TD Bristol, UK.
  • Sacharz J; Department of Biochemistry and Pharmacology, The Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC, Australia.
  • McConville C; Department of Biochemistry and Pharmacology, The Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC, Australia.
  • Moody ERR; School of Biological Sciences, University of Bristol, BS8 1TD Bristol, UK.
  • Shaw S; School of Biochemistry, Biomedical Sciences Building, University of Bristol, BS8 1TD Bristol, UK.
  • Planelles-Herrero VJ; MRC Laboratory of Molecular Biology, CB2 0QH Cambridge, UK.
  • Yadav SKN; School of Biochemistry, Biomedical Sciences Building, University of Bristol, BS8 1TD Bristol, UK.
  • Ross J; School of Biochemistry, Biomedical Sciences Building, University of Bristol, BS8 1TD Bristol, UK.
  • Borucu U; School of Biochemistry, Biomedical Sciences Building, University of Bristol, BS8 1TD Bristol, UK.
  • Palmer CS; Department of Biochemistry and Pharmacology, The Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC, Australia.
  • Chen KE; Centre for Cell Biology of Chronic Disease, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.
  • Croll TI; Cambridge Institute for Medical Research, University of Cambridge, CB2 0XY Cambridge, UK.
  • Hall RJ; Centre for Cell Biology of Chronic Disease, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.
  • Caruana NJ; Department of Biochemistry and Pharmacology, The Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC, Australia; Institute of Health and Sport (iHeS), Victoria University, Melbourne, VIC Australia.
  • Ghai R; Centre for Cell Biology of Chronic Disease, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia.
  • Nguyen THD; MRC Laboratory of Molecular Biology, CB2 0QH Cambridge, UK.
  • Heesom KJ; Proteomics Facility, School of Biochemistry, Biomedical Sciences Building, University of Bristol, BS8 1TD Bristol, UK.
  • Saitoh S; Department of Pediatrics and Neonatology, Nagoya City University Graduate School of Medical Sciences and Medical School, Nagoya, Japan.
  • Berger I; School of Biochemistry, Biomedical Sciences Building, University of Bristol, BS8 1TD Bristol, UK; Max Planck Bristol Centre for Minimal Biology, Department of Chemistry, University of Bristol, BS8 1TS Bristol, UK.
  • Schaffitzel C; School of Biochemistry, Biomedical Sciences Building, University of Bristol, BS8 1TD Bristol, UK.
  • Williams TA; School of Biological Sciences, University of Bristol, BS8 1TD Bristol, UK.
  • Stroud DA; Department of Biochemistry and Pharmacology, The Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC, Australia; Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, VIC Australia.
  • Derivery E; MRC Laboratory of Molecular Biology, CB2 0QH Cambridge, UK.
  • Collins BM; Centre for Cell Biology of Chronic Disease, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia. Electronic address: b.collins@imb.uq.edu.au.
  • Cullen PJ; School of Biochemistry, Biomedical Sciences Building, University of Bristol, BS8 1TD Bristol, UK. Electronic address: pete.cullen@bristol.ac.uk.
Cell ; 186(10): 2219-2237.e29, 2023 05 11.
Article en En | MEDLINE | ID: mdl-37172566
The Commander complex is required for endosomal recycling of diverse transmembrane cargos and is mutated in Ritscher-Schinzel syndrome. It comprises two sub-assemblies: Retriever composed of VPS35L, VPS26C, and VPS29; and the CCC complex which contains twelve subunits: COMMD1-COMMD10 and the coiled-coil domain-containing (CCDC) proteins CCDC22 and CCDC93. Combining X-ray crystallography, electron cryomicroscopy, and in silico predictions, we have assembled a complete structural model of Commander. Retriever is distantly related to the endosomal Retromer complex but has unique features preventing the shared VPS29 subunit from interacting with Retromer-associated factors. The COMMD proteins form a distinctive hetero-decameric ring stabilized by extensive interactions with CCDC22 and CCDC93. These adopt a coiled-coil structure that connects the CCC and Retriever assemblies and recruits a 16th subunit, DENND10, to form the complete Commander complex. The structure allows mapping of disease-causing mutations and reveals the molecular features required for the function of this evolutionarily conserved trafficking machinery.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anomalías Múltiples / Anomalías Craneofaciales / Complejos Multiproteicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cell Año: 2023 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anomalías Múltiples / Anomalías Craneofaciales / Complejos Multiproteicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cell Año: 2023 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos